| SSc (N = 9) | Controls (N = 4) | ||
---|---|---|---|---|
Mean or % | SD or N | Mean or % | SD or N | |
Age, years | 52.8 | 16.2 | 37.2 | 19.8 |
Female, % | 100 | 9 | 100 | 4 |
Ethnicity, % | Â | Â | Â | Â |
Caucasian | 77.8 | 7 | 50 | 2 |
Asian | 22.2 | 2 | 25 | 1 |
Other | – | 0 | 25 | 1 |
Smoking, % | Â | Â | Â | Â |
Current | 11.1 | 1 | – | 0 |
Past | 22.2 | 2 | 25 | 1 |
Never | 55.6 | 5 | 75 | 3 |
Unknown | 11.1 | 1 | – | 0 |
Disease duration, years | 10.4 | 7.0 | Â | Â |
Interstitial lung disease, % | 11.1 | 1 | Â | Â |
Arthritis, % | 11.1 | 1 | Â | Â |
Myositis, % | 22.2 | 2 | Â | Â |
Raynaud’s, % | 100 | 9 |  |  |
Anti-nuclear antibodies | Â | Â | Â | Â |
Titer ≥ 1:80, % | 100 | 9 |  |  |
Titer ≥ 1:160, % | 66.7 | 6 |  |  |
Titer ≥ 1:640, % | 55.6 | 5 |  |  |
Blood biochemical indices | Â | Â | Â | Â |
C-reactive protein (CRP), mg/L | 29.5 | 65.3¶ |  |  |
Erythrocyte sedimentation rate, mm/hr | 23.7 | 14.1 | Â | Â |
Abs. whole blood cell (WBC), K/μL | 8.2 | 4.6 |  |  |
Abs. lymphocytes, K/μL | 1.6 | 0.7 |  |  |
Abs. monocytes, K/μL | 0.7 | 0.7¶ |  |  |
Disease-specific variables | Â | Â | Â | Â |
Limited skin disease, % | 33.3 | 3 | Â | Â |
Diffuse skin disease, % | 66.7 | 6 | Â | Â |
Immunosuppressive medication§, % | 33.3 | 3 |  |  |